Adoption of ‘Rolling Review’ for innovative drugs, shortening 6 months of approval process
“The key feature of the Special Act is the ‘Rolling Review’ which exclusively review products indicated as innovative drugs. It’s completely different from the current Prompt Approval and Review System.”
The core of the ‘Special Act on Innovative Drug Development-Approval Support(hereinafter ref...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
